NuGen Medical Devices Inc.
NGMD.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.54% | 79.07% | 44.44% | 3.48% | -5.73% |
| Total Depreciation and Amortization | -7.08% | -10.37% | -7.91% | -12.69% | -9.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -176.66% | -214.76% | -91.00% | -5.70% | -44.07% |
| Change in Net Operating Assets | -153.52% | -205.92% | 61.72% | 1,126.21% | 222.18% |
| Cash from Operations | -58.53% | 16.93% | 31.49% | 44.14% | 37.36% |
| Capital Expenditure | -1,977.27% | -236.36% | -236.36% | -- | -175.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.43% | 97.63% | 96.81% | 96.78% | -- |
| Cash from Investing | -14.60% | 79.30% | 78.39% | 90.88% | -4,950.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 99.19% | 96.81% | 98.05% | 94.83% |
| Issuance of Common Stock | 388.65% | 66.09% | 40.93% | -89.20% | -70.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 391.99% | 88.95% | 55.76% | 50.05% | -66.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 148.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 593.56% | 13,857.64% | 1,759.38% | 413.86% | -190.89% |